Skip to content

← All news

Markets

Protagonist Therapeutics authorizes $300 million buyback plan

1 source ·1 article ·Sep 8, 20:08 UTC Protagonist Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com News ·Sep 8, 20:08 UTC

Protagonist Therapeutics authorizes $300 million buyback plan